Correlation Between Sutro Biopharma and NRX Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sutro Biopharma and NRX Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sutro Biopharma and NRX Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sutro Biopharma and NRX Pharmaceuticals, you can compare the effects of market volatilities on Sutro Biopharma and NRX Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sutro Biopharma with a short position of NRX Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sutro Biopharma and NRX Pharmaceuticals.

Diversification Opportunities for Sutro Biopharma and NRX Pharmaceuticals

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Sutro and NRX is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Sutro Biopharma and NRX Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRX Pharmaceuticals and Sutro Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sutro Biopharma are associated (or correlated) with NRX Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRX Pharmaceuticals has no effect on the direction of Sutro Biopharma i.e., Sutro Biopharma and NRX Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sutro Biopharma and NRX Pharmaceuticals

Given the investment horizon of 90 days Sutro Biopharma is expected to generate 1.27 times more return on investment than NRX Pharmaceuticals. However, Sutro Biopharma is 1.27 times more volatile than NRX Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. NRX Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  88.00  in Sutro Biopharma on August 15, 2025 and sell it today you would earn a total of  5.00  from holding Sutro Biopharma or generate 5.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sutro Biopharma  vs.  NRX Pharmaceuticals

 Performance 
       Timeline  
Sutro Biopharma 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sutro Biopharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, Sutro Biopharma displayed solid returns over the last few months and may actually be approaching a breakup point.
NRX Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days NRX Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, NRX Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Sutro Biopharma and NRX Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sutro Biopharma and NRX Pharmaceuticals

The main advantage of trading using opposite Sutro Biopharma and NRX Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sutro Biopharma position performs unexpectedly, NRX Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will offset losses from the drop in NRX Pharmaceuticals' long position.
The idea behind Sutro Biopharma and NRX Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges